Page 145 - Biomarkers for risk stratification and guidance in heart failure
P. 145
Chapter 6
A
B
Supplemental figure 1. Kaplan-Meier curve for the combined endpoint HF readmission or mortality (a) and mortality (b) by 20% change in eGFR and change in NT-proBNP concentration.
Change in eGFR was defined as 1) an increase in eGFR more than 20% (eGFR ↑ > 20%), 2) a change in eGFR less than 20% (eGFR =) and a decrease in eGFR more than 20% (eGFR ↓ > 20%).
144
